RNAi Therapeutics Market Forecast 2027
                     RNAi Therapeutics Market Global 
Analysis and Forecast to 2027
Published Date : Aug 2020
 
Email: [email protected]
Email: [email protected]
Report Studies
 RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis 
by Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA)); 
Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, 
Cardiovascular, Respiratory Disorders, Infectious Diseases, Renal Diseases, and 
Other); Route of Administration (Intradermal Injections, Pulmonary Delivery, 
Intravenous Injections, Intraperitoneal Injections, and Others); End User 
(Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals), and 
Geography
2
Email: [email protected]
RNAi Therapeutics Market 
Overview
 The RNAi Therapeutics market is expected to grow from US$ 618.79 million in 2019 to US$ 
1,209.29 million by 2027; it is expected to register a CAGR of 8.8% from 2020 to 2027.
 The global impacts of COVID-19 are being felt across several markets. In case of 
pharmaceutical industry, supply chain operations are significantly hampered due to the 
pandemic. However, market players in the RNAi therapeutics are focusing on the 
development of vaccine with the help of gene silencing technology, which might have a 
positive impact on the market growth during the forecast period.
3
Email: [email protected]
Key Segment Market
 By Molecule Type (Small Interfering RNAs (siRNA) and MicroRNA (miRNA))
 By Application (Genetic Disorders, Oncology, Neurodegenerative Disorders, Cardiovascular, 
Respiratory Disorders, Infectious Diseases, Renal Diseases, and Other)
 By Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous 
Injections, Intraperitoneal Injections, and Others)
 By End User (Diagnostic Laboratories, Research and Academic Laboratories, and Hospitals)
4
Email: [email protected]
$50,000
RNAi Therapeutics 
$40,000
Market Value
$30,000
CAGR of  8.8% 
$20,000
(2020 - 2027)
$10,000
$0
20XX 20XX 20XX 20XX 20XX
5
Email: [email protected]
Company Profiles
 Alnylam Pharmaceuticals, Inc.
 Sanofi
 Olix Pharmaceuticals, Inc.
 Glaxosmithkline Plc.
 Benitec Biopharma
 Arbutus Biopharma Corporation
 Silence Therapeutics
 Rexahn Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc
 Quark
6
Email: [email protected]
By Geography
 North America (the US, Canada, and Mexico)
 Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)
 Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)
 Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & 
Africa)
 South & Central America (Brazil, Argentina, and the Rest of South & Central America).
7
 
THANK
YOU! Phone : +1-646-491-9876
E-Mail : [email protected]